Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves multiple interacting cell types driven by numerous cytokines and autoimmune epitopes. Although the initiating events leading to SLE pathology are not understood, there is a growing realization that dysregulated cytokine action on immune cells plays an important role in promoting the inflammatory autoimmune state. We applied phospho-specific flow cytometry to characterize the extent to which regulation of cytokine signal transduction through the STAT family of transcription factors is disturbed during the progression of SLE. Using a panel of 10 cytokines thought to have causal roles in the disease, we measured signaling responses at the single-cell level in five immune cell types from the MRLlpr murine model. This generated a highly multiplexed view of how cytokine stimuli are processed by intracellular signaling networks in adaptive and innate immune cells during different stages of SLE pathogenesis. We report that robust changes in cytokine signal transduction occur during the progression of SLE in multiple immune cell subtypes including increased T cell responsiveness to IL-10 and ablation of Stat1 responses to IFNalpha, IFNgamma, IL-6, and IL-21, Stat3 responses to IL-6, Stat5 responses to IL-15, and Stat6 responses to IL-4. We found increased intracellular expression of Suppressor of Cytokine Signaling 1 protein correlated with negative regulation of Stat1 responses to inflammatory cytokines. The results provide evidence of negative feedback regulation opposing inflammatory cytokines that have self-sustaining activities and suggest a cytokine-driven oscillator circuit may drive the periodic disease activity observed in many SLE patients.
Hale
Matthew B
MB
The Baxter Laboratory of Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
Krutzik
Peter O
PO
Samra
Shamsher S
SS
Crane
Janelle M
JM
Nolan
Garry P
GP
D000818:Animals; D015153:Blotting, Western; D016207:Cytokines / Q000378:metabolism*; D018450:Disease Progression; D008180:Lupus Erythematosus, Systemic / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050791:STAT Transcription Factors / Q000378:metabolism*; D015398:Signal Transduction
D016207:Cytokines; D050791:STAT Transcription Factors
J Immunol. 1982 Dec;129(6):2612-5
6815273
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
12604793
J Immunol. 2004 Mar 1;172(5):2731-8
14978070
Nature. 1997 Jun 26;387(6636):917-21
9202125
Immunol Rev. 2008 Jun;223:39-59
18613829
Ann N Y Acad Sci. 2005 Dec;1062:146-54
16461797
Virology. 1999 Mar 30;256(1):8-14
10087221
Curr Opin Immunol. 2004 Dec;16(6):801-7
15511676
J Exp Med. 1994 Jan 1;179(1):305-10
8270873
Nature. 1997 Jun 26;387(6636):921-4
9202126
J Immunol. 2005 Jun 1;174(11):6791-802
15905520
Annu Rev Immunol. 1998;16:293-322
9597132
J Exp Med. 1990 Jul 1;172(1):7-12
2141631
Biochem J. 2004 Mar 1;378(Pt 2):449-60
14611646
Cytometry A. 2003 Oct;55(2):61-70
14505311
Immunol Rev. 2003 Apr;192:196-211
12670405
Acta Oncol. 1991;30(4):537-40
1854511
J Autoimmun. 2003 Feb;20(1):15-25
12604309
Arthritis Rheum. 1981 Nov;24(11):1396-1402
6172132
J Immunol. 2005 Aug 15;175(4):2366-73
16081807
Cell. 2004 Jul 23;118(2):217-28
15260991
J Immunol. 2005 Aug 15;175(4):2357-65
16081806
Inflamm Res. 1999 May;48(5):255-61
10391113
J Exp Med. 2003 Mar 17;197(6):777-88
12642605
Immunol Res. 2002;25(2):143-53
11999168
Science. 2008 Jul 4;321(5885):126-9
18599789
Cell. 1996 May 3;85(3):303-6
8616885
Cell. 1998 May 1;93(3):385-95
9590173
Nat Immunol. 2003 Jun;4(6):540-5
12754505
Immunity. 2006 Sep;25(3):383-92
16979570
J Biol Chem. 2003 Jan 3;278(1):661-71
12403768
Semin Immunol. 2004 Dec;16(6):351-65
15541651
Clin Exp Immunol. 1999 Jan;115(1):189-95
9933441
Science. 2005 Apr 22;308(5721):523-9
15845847
J Clin Invest. 1998 Jan 15;101(2):364-71
9435308
Genes Immun. 2006 Mar;7(2):156-68
16508641
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13130-4
9789053
J Immunol. 2004 Jul 15;173(2):737-46
15240659
Rheum Dis Clin North Am. 1998 May;24(2):423-56
9606766
EMBO J. 1999 Mar 1;18(5):1309-20
10064597
Science. 2001 Nov 16;294(5546):1540-3
11711679
Curr Biol. 2005 Dec 6;15(23):R961-3
16332526
J Exp Med. 1978 Nov 1;148(5):1198-215
309911
Nucleic Acids Res. 1998 Jan 1;26(1):362-7
9399875
Clin Exp Immunol. 2000 Dec;122(3):464-70
11122256
Arthritis Rheum. 2000 Aug;43(8):1790-800
10943869
J Exp Med. 1999 Jun 7;189(11):1799-814
10359584
Lupus. 2000;9(9):664-71
11199920
J Clin Invest. 2000 Jul;106(2):207-15
10903336
Nat Biotechnol. 2002 Feb;20(2):155-62
11821861
J Exp Med. 2003 Mar 17;197(6):711-23
12642603